HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY
Technology
E-065-2017
Patent ID
E-065-2017-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
62/508,827
IC
NCI
Date Filed
Date Issued
Patent PDF